Redox control of G1/S cell cycle regulators during nitric oxide-mediated cell cycle arrest
✍ Scribed by Qi Lu; Frances L. Jourd'heuil; David Jourd'heuil
- Book ID
- 102882210
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 661 KB
- Volume
- 212
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Redox regulation of cell cycle progression during nitric oxide (NO) mediated cytostasis is not well‐understood. In this study, we investigated the role of the intracellular antioxidant glutathione (GSH) in regulating specific signaling events that are associated with NO‐mediated cell cycle arrest. Manipulation of intracellular GSH content through pharmacological inhibition of glutamate‐cysteine ligase (GCL) indicated that GSH depletion potentiated nitrosative stress, DNA damage, phosphorylation of the tumor suppressor p53 (Ser‐18) and upregulation of p21^cip1/waf1^ upon NO stimulation. However, we found that neither overexpression of a dominant negative p53 nor pharmacological inhibition of p53 with cyclic pifithrin‐α (cPFT‐α) was sufficient to reverse NO‐mediated cell cycle arrest or hypophosphorylation of retinoblastoma protein (Rb). We found that the decrease in cyclin D1 levels induced by NO was GSH‐sensitive implying that the redox regulation of NO‐mediated cytostasis was a multifaceted process and that both p53/p21^cip1/waf1^ and p53 independent cyclin D1 pathways were involved. Together, our results demonstrate that GSH serves as an important component of cellular protective mechanisms against NO‐derived nitrosative stress to regulate DNA damage checkpoint. J. Cell. Physiol. 212:827–839, 2007. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A prominent role for the execution of cell cycle and growth regulatory mechanisms within the three‐dimensional context of nuclear architecture is becoming increasingly evident. Signaling pathways and regulatory networks that govern activation and suppression of genes controlling prolife
Previous work based on mono-methyl selenium compounds that are putative precursors of methylselenol has strongly implicated this metabolite in the induction of caspase-mediated apoptosis of human prostate carcinoma and leukemia cells and G1 arrest in human vascular endothelial and cancer epithelial